• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与日本成年人非结核分枝杆菌病相关的合并症:一项理赔数据分析。

Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis.

机构信息

Department of Infectious Diseases, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, Japan.

Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

出版信息

BMC Pulm Med. 2020 Oct 9;20(1):262. doi: 10.1186/s12890-020-01304-6.

DOI:10.1186/s12890-020-01304-6
PMID:33036598
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7547454/
Abstract

BACKGROUND

Nontuberculous mycobacterial (NTM) lung disease is one of a growing number of chronic health problems that is difficult to cure in aging societies. While it is important to be vigilant about associated comorbidities in order to provide better patient care, data on the prevalence of comorbidities stratified by country or region are scarce. We aimed to elucidate the comorbidities associated with NTM disease based on Japanese health insurance claims data.

METHODS

Cross-sectional analyses were performed using the claims data for 2014 provided by the Japan Medical Data Center Co., Ltd. Patients aged 20-75 years with ≥3 claims associated with NTM disease were identified and matched to 10 sex-and-age-matched controls that had never made a claim for NTM disease. Thirty-one comorbidities previously suspected to be associated with NTM disease were selected, and the prevalence of these comorbidities compared between cases and controls.

RESULT

Overall, 419 NTM patients (134 males and 285 females) and 4190 non-NTM controls were identified from the JMDC database. Aspergillosis, asthma, chronic heart failure, diffuse panbronchiolitis, gastroesophageal reflux, interstitial pneumonia, lung cancer, cancer other than breast, lung, ovary, or prostate cancer, and rheumatoid arthritis were associated with NTM disease in both males and females. Chronic obstructive pulmonary disease was associated with NTM in males while chronic kidney disease, osteoporosis, and Sjögren syndrome were associated with NTM in females.

CONCLUSION

NTM disease was associated with multiple comorbidities that should be considered when providing medical care to individuals with NTM disease.

摘要

背景

非结核分枝杆菌(NTM)肺病是老龄化社会中越来越多的慢性健康问题之一,难以治愈。虽然警惕与该病相关的合并症对于提供更好的患者护理很重要,但按国家或地区划分的合并症患病率数据却很少。我们旨在根据日本健康保险索赔数据阐明与 NTM 疾病相关的合并症。

方法

使用日本医疗数据中心有限公司提供的 2014 年的索赔数据进行横断面分析。确定年龄在 20-75 岁之间、有≥3 次与 NTM 疾病相关的索赔记录的患者,并与从未提出过 NTM 疾病索赔的 10 名性别和年龄匹配的对照者相匹配。选择了 31 种先前怀疑与 NTM 疾病相关的合并症,并比较了病例组和对照组中这些合并症的患病率。

结果

总体而言,从 JMDC 数据库中确定了 419 名 NTM 患者(男性 134 名,女性 285 名)和 4190 名非 NTM 对照者。在男性和女性中,曲霉菌病、哮喘、慢性心力衰竭、弥漫性泛细支气管炎、胃食管反流、间质性肺炎、肺癌、乳腺癌、肺癌、卵巢癌或前列腺癌以外的癌症以及类风湿关节炎与 NTM 疾病相关。在男性中,慢性阻塞性肺疾病与 NTM 相关,而在女性中,慢性肾脏病、骨质疏松症和干燥综合征与 NTM 相关。

结论

NTM 疾病与多种合并症相关,在为 NTM 疾病患者提供医疗护理时应考虑这些合并症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bbc/7547454/4a23d40772f6/12890_2020_1304_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bbc/7547454/4a23d40772f6/12890_2020_1304_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bbc/7547454/4a23d40772f6/12890_2020_1304_Fig1_HTML.jpg

相似文献

1
Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis.与日本成年人非结核分枝杆菌病相关的合并症:一项理赔数据分析。
BMC Pulm Med. 2020 Oct 9;20(1):262. doi: 10.1186/s12890-020-01304-6.
2
Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.日本非结核分枝杆菌肺病患者的成人和儿童治疗的流行病学。
Ann Am Thorac Soc. 2019 Mar;16(3):341-347. doi: 10.1513/AnnalsATS.201806-366OC.
3
Predictive modeling of nontuberculous mycobacterial pulmonary disease epidemiology using German health claims data.使用德国健康索赔数据对非结核分枝杆菌肺病流行病学进行预测建模。
Int J Infect Dis. 2021 Mar;104:398-406. doi: 10.1016/j.ijid.2021.01.003. Epub 2021 Jan 11.
4
Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.2007年至2012年俄勒冈州非结核分枝杆菌肺病的人群发病率
Ann Am Thorac Soc. 2015 May;12(5):642-7. doi: 10.1513/AnnalsATS.201412-559OC.
5
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.日本一家转诊医院中,非结核分枝杆菌肺病和结核病的流行病学和临床特征的相互关系变化。
Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8.
6
Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China.中国南京地区非结核分枝杆菌肺病的特征。
BMC Infect Dis. 2019 Sep 2;19(1):764. doi: 10.1186/s12879-019-4412-6.
7
Effect of comorbidities on mortality in patients with nontuberculous mycobacterial infection in Korea: National Health Insurance Service-National Sample Cohort data.韩国非结核分枝杆菌感染患者合并症对死亡率的影响:国家健康保险服务-国家样本队列数据。
Sci Rep. 2024 Oct 1;14(1):22815. doi: 10.1038/s41598-024-73768-z.
8
Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016.中国南方地区非结核分枝杆菌肺病的流行病学研究,2013-2016 年。
BMC Pulm Med. 2018 Nov 9;18(1):168. doi: 10.1186/s12890-018-0728-z.
9
Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease.非结核分枝杆菌性肺病的医疗保险受益人的住院风险。
Chest. 2021 Dec;160(6):2042-2050. doi: 10.1016/j.chest.2021.07.034. Epub 2021 Jul 24.
10
Current challenges in pulmonary nontuberculous mycobacterial infection: a case series with literature review.肺部非结核分枝杆菌感染的当前挑战:病例系列及文献复习。
Postgrad Med. 2024 Sep;136(7):770-781. doi: 10.1080/00325481.2024.2401766. Epub 2024 Sep 12.

引用本文的文献

1
Chronic obstructive pulmonary disease is a risk factor for non-tuberculous mycobacterial pulmonary disease: a population-based matched cohort study.慢性阻塞性肺疾病是非结核分枝杆菌肺病的一个危险因素:一项基于人群的匹配队列研究。
BMJ Open Respir Res. 2025 Jun 20;12(1):e002373. doi: 10.1136/bmjresp-2024-002373.
2
Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series.寻常型间质性肺炎模式与分枝杆菌肺病:病例系列
Infect Dis Rep. 2025 Apr 3;17(2):28. doi: 10.3390/idr17020028.
3
Comprehensive Management Algorithm for Complex Pulmonary Disease in the Real-World Setting.

本文引用的文献

1
Low serum estradiol levels are related to Mycobacterium avium complex lung disease: a cross-sectional study.低血清雌二醇水平与鸟分枝杆菌复合体肺病有关:一项横断面研究。
BMC Infect Dis. 2019 Dec 16;19(1):1055. doi: 10.1186/s12879-019-4668-x.
2
COPD as an independent risk factor for osteoporosis and fractures.COPD 是骨质疏松症和骨折的独立危险因素。
Osteoporos Int. 2020 Apr;31(4):687-697. doi: 10.1007/s00198-019-05235-9. Epub 2019 Dec 6.
3
Pulmonary Involvement in Sjögren Syndrome.干燥综合征的肺部受累。
真实世界中复杂肺部疾病的综合管理算法
Ann Am Thorac Soc. 2025 May;22(5):651-659. doi: 10.1513/AnnalsATS.202408-904FR.
4
A novel hematological score (HS) and its related nomogram model to predict nontuberculous mycobacterial pulmonary disease in patients with suspected multidrug-resistant pulmonary tuberculosis.一种新型血液学评分(HS)及其相关列线图模型,用于预测疑似耐多药肺结核患者中的非结核分枝杆菌性肺病。
Ann Med. 2024 Dec;56(1):2409965. doi: 10.1080/07853890.2024.2409965. Epub 2024 Sep 30.
5
Drug-drug interactions in the management of non-tuberculous mycobacterial infections.非结核分枝杆菌感染管理中的药物相互作用。
Front Microbiol. 2024 Sep 5;15:1468383. doi: 10.3389/fmicb.2024.1468383. eCollection 2024.
6
Nontuberculous mycobacterial pulmonary disease added burden to COPD and bronchiectasis in Japan.非结核分枝杆菌肺病给日本的慢性阻塞性肺疾病和支气管扩张症增加了负担。
ERJ Open Res. 2024 Jul 8;10(4). doi: 10.1183/23120541.00911-2023. eCollection 2024 Jul.
7
Proposed Etiotypes for Chronic Obstructive Pulmonary Disease: Controversial Issues.慢性阻塞性肺疾病的拟议病因类型:争议问题。
Tuberc Respir Dis (Seoul). 2024 Jul;87(3):221-233. doi: 10.4046/trd.2023.0194. Epub 2024 Feb 6.
8
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis.囊性纤维化患者中非结核分枝杆菌肺病的临床管理中可治疗的特征和挑战。
Respir Res. 2023 Dec 16;24(1):316. doi: 10.1186/s12931-023-02612-1.
9
Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review.非结核分枝杆菌性肺病的全球流行病学:综述。
Clin Chest Med. 2023 Dec;44(4):675-721. doi: 10.1016/j.ccm.2023.08.012. Epub 2023 Sep 21.
10
Validity of claims-based diagnoses for infectious diseases common among immunocompromised patients in Japan.基于日本免疫功能低下患者常见传染病的诊断主张的有效性。
BMC Infect Dis. 2023 Oct 3;23(1):653. doi: 10.1186/s12879-023-08466-8.
Clin Chest Med. 2019 Sep;40(3):531-544. doi: 10.1016/j.ccm.2019.05.002. Epub 2019 Jul 6.
4
Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection.慢性丙型肝炎病毒感染患者抗病毒治疗与帕金森病风险的关联
JAMA Neurol. 2019 Sep 1;76(9):1019-1027. doi: 10.1001/jamaneurol.2019.1368.
5
Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims Data.日本慢性丙型肝炎患者接受与未接受抗病毒治疗的临床和经济负担:一项使用医院理赔数据的观察性队列研究
Infect Dis Ther. 2019 Jun;8(2):285-299. doi: 10.1007/s40121-019-0234-5. Epub 2019 Feb 15.
6
Development of lung cancer in patients with nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病患者肺癌的发生
Respir Investig. 2019 Mar;57(2):157-164. doi: 10.1016/j.resinv.2018.11.004. Epub 2018 Dec 28.
7
Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population.美国管理式医疗人群中非结核分枝杆菌肺病患者全因死亡率的相对风险。
Respir Med. 2018 Dec;145:80-88. doi: 10.1016/j.rmed.2018.10.022. Epub 2018 Oct 22.
8
Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.日本非结核分枝杆菌肺病患者的成人和儿童治疗的流行病学。
Ann Am Thorac Soc. 2019 Mar;16(3):341-347. doi: 10.1513/AnnalsATS.201806-366OC.
9
A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.一项回顾性分析,旨在探讨原发性干燥综合征相关间质性肺病在中国人群中的胸部高分辨率 CT 特征及临床表现。
Clin Rheumatol. 2018 Nov;37(11):2981-2988. doi: 10.1007/s10067-018-4289-6. Epub 2018 Sep 22.
10
Health Care Utilization and Expenditures Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the United States.美国非结核分枝杆菌肺病诊断后的医疗保健利用和支出。
J Manag Care Spec Pharm. 2018 Oct;24(10):964-974. doi: 10.18553/jmcp.2018.18122. Epub 2018 Jul 20.